Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation

NCT03256942 is registered in ClinicalTrials.gov with Merz Pharmaceuticals GmbH as lead sponsor.

NCT NCT03256942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03256942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation
Lead sponsor
Merz Pharmaceuticals GmbH
Phase
Not applicable
Overall status
Completed
Start date
August 16, 2017
Completion date
November 17, 2017
Enrollment
75 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

subjects desiring lip augmentation